Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Ketamine advertisements are popping up all around us. With few regulations in place, might we be witnessing another opioid ...

The government is preparing to fund the use of MDMA and psylocibin, otherwise known as ecstasy and magic mushrooms, as a ...

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) revealed the topline data from the Phase 2b study of SPN-820 in adults with ...

Psychedelics have been recreational substances for decades. Now, they're entering the mainstream of psychiatric treatment.

Faster-acting drugs have long been sought to protect people with severe depression who may be at risk of self-harm or suicide ...

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

A Placer County man is sharing his personal story of recovery from severe suicidal depression. David Bartley found relief in ...

In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality ...

IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...